MedPath

PEEL THERAPEUTICS, INC

PEEL THERAPEUTICS, INC logo
🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

1

Active:0
Completed:0

Trial Phases

1 Phases

Phase 1:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Phase 1
1 (100.0%)

A Study to Evaluate PEEL-224 in Patients With Advanced Solid Tumors

Phase 1
Recruiting
Conditions
Advanced Solid Tumor
Interventions
Drug: FOLF+B
First Posted Date
2022-04-14
Last Posted Date
2025-06-17
Lead Sponsor
Peel Therapeutics Inc
Target Recruit Count
65
Registration Number
NCT05329103
Locations
🇺🇸

HonorHealth Research Institiute, Scottsdale, Arizona, United States

🇺🇸

Stanford Cancer Center, Palo Alto, California, United States

🇺🇸

Carolina BioOncology Institute, Huntersville, North Carolina, United States

and more 4 locations

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.